Coca-Cola Consolidated, Inc.
COKE
$0.00
-1.14%
Coca-Cola Consolidated, Inc. is a major distributor, marketer, and manufacturer of nonalcoholic beverages in the United States, operating within the Consumer Defensive sector. The company is a key anchor bottler for The Coca-Cola Company, holding exclusive territories and serving as a critical link in the supply chain for a wide portfolio of sparkling and still beverages. The current investor narrative centers on the company's robust financial performance, highlighted by strong revenue growth and significant free cash flow generation, which has fueled substantial shareholder returns through aggressive stock buybacks, as evidenced by recent quarterly cash flow statements showing billions in repurchases. However, attention is also focused on the stock's significant volatility and recent sharp price correction from its highs, raising questions about valuation sustainability amidst its impressive year-to-date performance.…
COKE
Coca-Cola Consolidated, Inc.
$0.00
Investment Opinion: Should I buy COKE Today?
Rating: Hold. The core thesis is that COKE is a fundamentally strong company caught in a valuation reset after a parabolic rally, presenting a 'wait and see' opportunity rather than an immediate buy.
Supporting Evidence: The recommendation is grounded in four key data points. First, valuation is schizophrenic: a tantalizingly low forward P/E of 4.66x conflicts with a more modest trailing P/E of 19.79x and a PEG ratio of 1.87. Second, revenue growth remains healthy at 9.03% YoY. Third, profitability is solid but showing cracks, with operating margin at 12.89% but net margin compressing. Fourth, shareholder returns are massive, with TTM free cash flow of $620.25 million funding aggressive buybacks. However, the lack of analyst consensus (only 1 analyst) and the stock's 9.88% decline over 3 months suggest caution is warranted.
Risks & Conditions: The two biggest risks are 1) further net margin compression invalidating the low forward P/E, and 2) the high volatility leading to another sharp downdraft. This Hold rating would upgrade to a Buy if the forward P/E proves accurate (i.e., next quarterly earnings show significant EPS growth), or if the stock stabilizes above $170 support and margins show sequential improvement. It would downgrade to a Sell if revenue growth decelerates below 5% or net margin falls below 6%. Relative to its own history and cash-generative profile, the stock appears fairly valued to slightly overvalued on a trailing basis, but potentially deeply undervalued on a forward basis if estimates hold.
Sign up to view all
COKE 12-Month Price Forecast
COKE presents a classic 'show me' story. The fundamentals—strong cash flow, defensive growth, and a cheap forward multiple—are compelling, but they are offset by clear deterioration in net profitability and extreme recent price volatility. The low analyst coverage adds to the uncertainty. The neutral stance reflects the high probability (60%) of a base case of range-bound trading as the market waits for clarity on the earnings trajectory. Confidence is medium due to the conflicting signals between valuation metrics. The stance would upgrade to bullish on confirmation of margin stabilization and a successful hold of the $170 support level. It would turn bearish on a breakdown below $170 accompanied by another quarter of margin decline.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coca-Cola Consolidated, Inc.'s 12-month outlook, with a consensus price target around $0.00 and implied upside of — versus the current price.
Average Target
$0.00
1 analysts
Implied Upside
—
vs. current price
Analyst Count
1
covering this stock
Price Range
$0 - $0
Analyst target range
Insufficient analyst coverage available. The data indicates only a single analyst providing estimates, with no recent price targets or consensus recommendation data presented. This limited coverage is typical for a small to mid-cap company like COKE, which has a market cap of approximately $11.3 billion. The implication is that the stock suffers from lower institutional visibility and less efficient price discovery, which can contribute to higher volatility as seen in its recent price swings. The lack of a robust analyst consensus means investors must rely more heavily on their own fundamental and technical analysis, and the stock may be more prone to mispricing due to the absence of a steady stream of professional research and valuation benchmarks.
Bulls vs Bears: COKE Investment Factors
The bull case for COKE is anchored in its powerful cash generation, defensive growth, and seemingly cheap forward valuation. The bear case highlights deteriorating net margins, recent severe price volatility, and an aggressive financial strategy that has distorted the balance sheet. Currently, the bearish evidence holds slightly stronger weight due to the sharp technical breakdown and fundamental margin pressure occurring after a massive rally. The single most important tension in the investment debate is the validity of the forward P/E of 4.66x. If the company can deliver the earnings growth implied by this multiple while sustaining its cash flow, the stock is profoundly undervalued. However, if margin compression continues or revenue growth falters, the current trailing P/E of 19.79x could expand, leading to further multiple contraction and price declines.
Bullish
- Exceptional Free Cash Flow Generation: The company generated $620.25 million in trailing twelve-month free cash flow, demonstrating a robust ability to convert earnings into cash. This strong cash flow directly funds aggressive shareholder returns, with $2.46 billion spent on stock repurchases in Q4 2025 alone, significantly reducing share count and boosting per-share metrics.
- Strong Revenue Growth & Defensive Profile: Q4 2025 revenue grew 9.03% year-over-year to $1.90 billion, driven by its core nonalcoholic beverage segment. This growth, combined with a low beta of 0.548, indicates the business is both expanding and less sensitive to broad market downturns, offering a rare combination of growth and stability.
- Attractive Valuation on Forward Earnings: The stock trades at a forward P/E of just 4.66x, suggesting the market is pricing in a substantial earnings increase. This is exceptionally low for a profitable company with 9% revenue growth and a 7.2% net margin, indicating significant potential upside if earnings meet expectations.
- Healthy Profitability & Operating Margins: The company maintains solid profitability with a gross margin of 38.21% and an operating margin of 12.89% for Q4 2025. Despite a recent compression in net margin from 10.25% to 7.21% due to higher interest expense, the core operational profitability remains strong.
Bearish
- Severe Net Margin Compression: Net margin contracted from 10.25% in Q4 2024 to 7.21% in Q4 2025, a decline of over 300 basis points. This was primarily driven by a six-fold increase in interest expense to $25.17 million and volatile other income/expense items, raising concerns about earnings quality and cost control.
- Extreme Volatility & Recent Weak Momentum: Despite a low beta, the stock has shown high idiosyncratic volatility, with a 24.66% maximum drawdown and a 9.88% decline over the last three months. The sharp correction from the March 2026 highs suggests the prior rally was unsustainable and momentum has decisively shifted negative in the near term.
- Aggressive Buybacks Masking Equity Erosion: Massive share repurchases have driven shareholder equity negative, resulting in a debt-to-equity ratio of -4.06 and a negative ROE of -77.1%. While funded by cash flow, this aggressive capital return strategy leaves the balance sheet with an unusual structure and reduces financial flexibility for future investments.
- Lack of Analyst Coverage & Visibility: Only one analyst provides estimates for COKE, with no consensus price target available. This limited institutional coverage contributes to inefficient price discovery, higher volatility, and a lack of external validation for the company's growth and valuation assumptions.
COKE Technical Analysis
The stock is in a pronounced long-term uptrend but has recently experienced a sharp correction from its peak. Over the past year, COKE has delivered a remarkable 70.94% price appreciation, yet as of the latest close of $181.54, it is trading approximately 17% below its 52-week high of $219.65, positioning it in the middle-upper range of its 52-week band. This retreat from the highs suggests the momentum that drove the stock to new peaks has cooled, potentially indicating a period of consolidation or profit-taking after an extended rally. The short-term momentum paints a picture of recent weakness conflicting with the strong annual trend. The stock is down 9.88% over the last three months but has shown a modest recovery attempt with a 4.72% gain over the past month. This 1-month positive move against the 3-month decline could signal an attempt at stabilization or the beginning of a basing pattern after the significant sell-off from March highs. The stock's beta of 0.548 indicates it has been significantly less volatile than the broader market, which is unusual given its recent price swings and suggests its volatility is largely idiosyncratic. Key technical levels are clearly defined, with immediate resistance at the 52-week high of $219.65 and support at the 52-week low of $105.98. A breakout above resistance would reaffirm the primary bull trend, while a sustained break below recent lows around $170 could signal a deeper correction. The stock's low beta relative to its own price action implies that its risk profile is not fully captured by market correlation, requiring closer attention to company-specific catalysts.
Beta
0.55
0.55x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$107-$220
Price range past year
Annual Return
+70.9%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | +4.7% | +0.1% |
| 3m | -9.9% | +13.9% |
| 6m | +9.2% | +8.5% |
| 1y | +70.9% | +25.6% |
| ytd | +21.2% | +9.5% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
COKE exhibits a strong and accelerating revenue growth trajectory. For the quarter ending December 31, 2025, revenue reached $1.90 billion, representing a solid 9.03% year-over-year growth. This growth is primarily driven by its core Nonalcoholic Beverage segment, which contributed $1.89 billion, or over 99%, of the total revenue. The sequential trend from recent quarters shows revenue climbing from $1.58 billion in Q1 2025 to the current level, indicating sustained demand and execution. The company is highly profitable with expanding margins. Net income for the latest quarter stood at $137.25 million, translating to a net margin of 7.21%. Gross margin was healthy at 38.21%, while the operating margin came in at 12.89%. Comparing to the year-ago quarter (Q4 2024), net margin has compressed from 10.25%, primarily due to a significant increase in interest expense ($25.17 million vs. $4.00 million) and other income/expense swings, though the gross margin remained stable. The balance sheet and cash flow position are exceptionally strong, characterized by massive shareholder returns. The company generated $209.65 million in operating cash flow and $107.33 million in free cash flow for the latest quarter. On a trailing twelve-month basis, free cash flow is a substantial $620.25 million. This robust cash generation is funding aggressive capital returns, as seen in the $2.46 billion spent on stock repurchases in Q4 alone. The current ratio is a solid 1.26, indicating good short-term liquidity, though the debt-to-equity ratio of -4.06 is an accounting anomaly resulting from significant stock buybacks reducing shareholder equity, not a sign of financial distress given the strong cash flows.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$620252000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. COKE trades at a trailing PE of 19.79x and a forward PE of 4.66x based on estimated earnings. The massive gap between trailing and forward PE suggests analysts are forecasting a substantial increase in earnings, implying the market is pricing in very high growth expectations for the coming period. Compared to sector averages, COKE's trailing PE of 19.79x is difficult to contextualize without a specific industry average provided, but its Price-to-Sales (PS) ratio of 1.56x and EV-to-Sales of 0.38x appear modest for a business with its growth and cash flow profile. The low EV/Sales multiple, in particular, suggests the enterprise value is low relative to revenue, potentially indicating value if the growth and margins are sustainable. Historically, the stock's own valuation has fluctuated significantly. The current trailing PE of 19.79x sits well below its recent historical highs seen in Q1 2025 (27.98x) and is more in line with levels from late 2024. This suggests the recent price correction has brought valuations down from peak optimism, though they remain above the lows seen in 2022 and 2023. The stock is not at bargain-basement historical levels but has de-rated from prior exuberance, potentially offering a more reasonable entry point if fundamentals remain intact.
PE
19.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: COKE faces significant financial risks stemming from its aggressive capital return policy. The $2.46 billion spent on buybacks in a single quarter, while funded by cash flow, has eroded shareholder equity to a negative position, creating a debt-to-equity ratio of -4.06. This limits balance sheet flexibility and makes traditional leverage ratios misleading. Operationally, net margin compression from 10.25% to 7.21% year-over-year, driven by a surge in interest expense, indicates rising financing costs and potential pressure on bottom-line profitability despite stable gross margins of ~38%. The company is also heavily reliant on its single Nonalcoholic Beverages segment, which constitutes over 99% of revenue, creating concentration risk.
Market & Competitive Risks: The stock's primary market risk is valuation compression following its explosive 70.94% annual gain. Trading 17% below its high, it remains susceptible to further de-rating if growth expectations moderate. The low beta of 0.548 suggests it is not highly correlated with the market, but its own volatility (24.66% max drawdown) is a major standalone risk. Competitive risks are inherent in the beverage distribution industry, including potential changes in terms with The Coca-Cola Company, pricing pressure from retailers, and shifting consumer preferences away from sugary drinks, though the portfolio includes still beverages.
Worst-Case Scenario: The worst-case scenario involves a continuation of net margin erosion coupled with a growth slowdown, triggering a double whammy of lower earnings and multiple compression. This could be catalyzed by a sustained increase in interest rates impacting financing costs further, or a misstep in execution leading to a loss of market share. In this adverse scenario, the stock could re-test its 52-week low of $105.98, representing a potential downside of approximately -42% from the current price of $181.54. A more realistic severe bear case might see the stock fall to the $140-$150 range, a -17% to -23% decline, as it prices in a recession in earnings growth and a return to a more normalized, higher P/E multiple.
FAQ
The key risks are, in order of severity: 1) Financial Model Risk: Aggressive buybacks have created negative equity (D/E: -4.06) and reliance on sustained high cash flow. 2) Profitability Risk: Net margin fell over 300 bps YoY to 7.21%; further compression would crush earnings growth. 3) Volatility & Liquidity Risk: The stock has high idiosyncratic volatility (24.66% max drawdown) and low analyst coverage, leading to sharp, unpredictable moves. 4) Concentration Risk: Over 99% of revenue comes from the nonalcoholic beverage segment, with heavy dependence on the Coca-Cola franchise.
The 12-month forecast presents three scenarios. The Base Case (60% probability) sees the stock trading between $170 and $200 as growth moderates and margins stabilize. The Bull Case (25% probability) projects a return to the $219+ high, driven by earnings meeting forward multiple expectations. The Bear Case (15% probability) warns of a drop towards the $106-$150 range if margin erosion continues. The most likely outcome is the Base Case of consolidation, as the market requires time to verify if the company's earnings can grow into its low forward multiple.
COKE's valuation is contradictory, making a simple call difficult. On a forward-looking basis, it appears deeply undervalued with a P/E of 4.66x. On a trailing basis, it looks fairly valued to slightly overvalued at a P/E of 19.79x, especially considering the margin compression. The low EV/Sales of 0.38x suggests the enterprise is cheap relative to revenue. Overall, the market is pricing in a substantial earnings acceleration. If that occurs, the stock is undervalued. If not, it is likely fairly valued or overvalued given the current profitability trajectory.
COKE is a Hold, not a clear-cut buy at present. The potential reward, implied by a 4.66x forward P/E and 21% upside to its 52-week high, is attractive. However, the risk is significant, given the 42% downside to its 52-week low, recent net margin compression, and high volatility. It could be a good buy for patient, risk-tolerant investors who believe the company will overcome its margin issues and deliver on forward earnings estimates. Conservative investors should wait for more evidence of fundamental stabilization.
COKE is more suitable for a medium-to-long-term investment horizon (2+ years). Its low beta (0.548) and defensive business model support a long-term hold, allowing investors to benefit from compounding cash flows and buybacks. However, its high recent volatility and unresolved margin issues make it a poor short-term trading vehicle, as unpredictable swings can quickly erode capital. The lack of a significant dividend (0.77% yield) also reduces its appeal for income-focused long-term holders. A minimum holding period of 2-3 years is suggested to allow the fundamental story to play out.